📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

The interferon gene signature is increased in patients with early treatment-naive rheumatoid arthritis and predicts a poorer response to initial therapy. (2018)

First Author: Cooles FAH

Attributed to: MICA: BIOlogical Factors that Limit sustAined Remission in rhEumatoid arthritis (the BIO-FLARE study) funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.jaci.2017.08.026

PubMed Identifier: 28987811

Publication URI: http://europepmc.org/abstract/MED/28987811

Type: Journal Article/Review

Volume: 141

Parent Publication: The Journal of allergy and clinical immunology

Issue: 1

ISSN: 0091-6749